Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Constantin Volkmann"'
Publikováno v:
Frontiers in Psychiatry, Vol 11 (2020)
Lithium has been the treatment of choice for patients with bipolar disorder (BD) for nearly 70 years. It is recommended by all relevant guidelines as a first-line treatment for maintenance therapy. In this review, we outline the current state of evid
Externí odkaz:
https://doaj.org/article/da4f8ca002c0416f9a61f5b143b994b6
Publikováno v:
PLoS ONE, Vol 15, Iss 11, p e0241497 (2020)
BackgroundThe average treatment effect of antidepressants in major depression was found to be about 2 points on the 17-item Hamilton Depression Rating Scale, which lies below clinical relevance. Here, we searched for evidence of a relevant treatment
Externí odkaz:
https://doaj.org/article/f4f3727a954f47ebbc38989ef551e488
Publikováno v:
Nervenheilkunde. 41:240-245
ZUSAMMENFASSUNGKetamin und Esketamin werden als rasch und stark wirksame Mittel zur Reduktion von Depressivität und Suizidalität beschrieben. Dieser Beitrag gibt einen Überblick zur Wirksamkeit von Ketamin und Esketamin zur Reduktion von suizidale
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8dba752dd0ebd400c617eb66c2a51d8f
https://doi.org/10.1055/a-1761-3192
https://doi.org/10.1055/a-1761-3192
Autor:
Alexander Volkmann, Pim Cuijpers, Eva-Lotta Brakemeier, Constantin Volkmann, Eirini Karyotaki, Tim Kaiser
Publikováno v:
Clinical Psychology: Science and Practice, 29(3), 294-303. Wiley-Blackwell
Kaiser, T, Volkmann, C, Volkmann, A, Karyotaki, E, Cuijpers, P & Brakemeier, E L 2022, ' Heterogeneity of Treatment Effects in Trials on Psychotherapy of Depression ', Clinical Psychology: Science and Practice, vol. 29, no. 3, pp. 294-303 . https://doi.org/10.1037/cps0000079
Kaiser, T, Volkmann, C, Volkmann, A, Karyotaki, E, Cuijpers, P & Brakemeier, E L 2022, ' Heterogeneity of Treatment Effects in Trials on Psychotherapy of Depression ', Clinical Psychology: Science and Practice, vol. 29, no. 3, pp. 294-303 . https://doi.org/10.1037/cps0000079
BackgroundPsychotherapy is an evidence-based treatment for depression, but its average effect is modest. Thus, identifying subgroups that respond especially well to psychotherapy is an important goal. This would allow maximizing the efficacy of inter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d0ea506fd10cf0b1feddb80cb594deb
https://research.vu.nl/en/publications/782cb4be-1634-40d5-97ed-13deb8802855
https://research.vu.nl/en/publications/782cb4be-1634-40d5-97ed-13deb8802855
Background: Discontinuing antidepressants after recovering from a depressive episode is associated with a risk for two events: discontinuation symptoms and relapse. Little is known about who can discontinue safely and whether discontinuation symptoms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2053324b11f0a91b7096f05ff7c7d0d4
https://doi.org/10.31234/osf.io/fxye5
https://doi.org/10.31234/osf.io/fxye5
Autor:
Constantin Volkmann, Philipp Sterzer
Publikováno v:
NeuroTransmitter. 32:42-47
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d08398176eb235b3eb7a8cd6b088aa2
https://doi.org/10.1007/s15016-021-9291-6
https://doi.org/10.1007/s15016-021-9291-6
Autor:
Marta M. Maslej, Toshiaki A. Furukawa, Andrea Cipriani, Paul W. Andrews, Marcos Sanches, Anneka Tomlinson, Constantin Volkmann, Robert A. McCutcheon, Oliver Howes, Xin Guo, Benoit H. Mulsant
Publikováno v:
JAMA psychiatry. 78(5)
Importance Antidepressants are commonly used to treat major depressive disorder (MDD). Antidepressant outcomes can vary based on individual differences; however, it is unclear whether specific factors determine this variability or whether it is at ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49ca000056d0a239e394422bb4d6cb71
https://pubmed.ncbi.nlm.nih.gov/33595616
https://pubmed.ncbi.nlm.nih.gov/33595616
BackgroundThe average treatment effect of antidepressants in major depression was found to be about 2 points on the 17-item Hamilton Depression Rating Scale, which lies below clinical relevance. Here, we searched for evidence of a relevant treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::890459e38f616f0498a468485010ba6e
https://doi.org/10.1101/2020.02.20.19015677
https://doi.org/10.1101/2020.02.20.19015677
Autor:
Simone Bauer, Kent E. Duncan, Eckart D. Gundelfinger, Ulrich Thomas, Benjamin Schattling, Nicola Rothammer, Gabriela Salinas, Manuel A. Friese, Jan Broder Engler, Meike Petersen, Doron Merkler, Simone Träger, Marcel S Woo, Iris Winkler, Sina C. Rosenkranz, Wolfgang Brück, Peter Soba, Anna Fejtova, Max Kaufmann, Katharine K. Miller, Constantin Volkmann, Aparajita Bose
Publikováno v:
Nature Neuroscience, Vol. 22, No 6 (2019) pp. 887-896
Multiple sclerosis (MS) is characterized by inflammatory insults that drive neuroaxonal injury. However, knowledge about neuron-intrinsic responses to inflammation is limited. By leveraging neuron-specific messenger RNA profiling, we found that neuro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f80b925110c15448b0fa62dbf3818707
https://pubmed.ncbi.nlm.nih.gov/31011226
https://pubmed.ncbi.nlm.nih.gov/31011226